Hisamitsu Pharmaceutical (Germany) Top Insiders
HPX Stock | EUR 25.80 1.20 4.88% |
Hisamitsu Pharmaceutical employs about 2.8 K people. The company is managed by 10 executives with a total tenure of roughly 6496 years, averaging almost 649.0 years of service per executive, having 278.4 employees per reported executive. Examination of Hisamitsu Pharmaceutical's management performance can provide insight into the company performance.
Kyu Saito Insider Head Officer |
Shinichiro Takao Insider Head MD |
Hisamitsu |
Hisamitsu Pharmaceutical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0212 % which means that it generated a profit of $0.0212 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0504 %, meaning that it generated $0.0504 on every $100 dollars invested by stockholders. Hisamitsu Pharmaceutical's management efficiency ratios could be used to measure how well Hisamitsu Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Hisamitsu Pharmaceutical Workforce Comparison
Hisamitsu Pharmaceutical Co is one of the top stocks in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 2,903. Hisamitsu Pharmaceutical totals roughly 2,784 in number of employees claiming about 96% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09. Hisamitsu Pharmaceutical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Hisamitsu Pharmaceutical Price Series Summation is a cross summation of Hisamitsu Pharmaceutical price series and its benchmark/peer.
Hisamitsu Pharmaceutical Notable Stakeholders
A Hisamitsu Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Hisamitsu Pharmaceutical often face trade-offs trying to please all of them. Hisamitsu Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Hisamitsu Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kyu Saito | Head Officer | Profile | |
Shinichiro Takao | Head MD | Profile | |
Mitsutoshi Tsuruta | Ex Division | Profile | |
Masaya Okuno | OTC Division | Profile | |
Kazuhide Nakatomi | CEO Pres | Profile | |
Koji Takiyama | Sr Director | Profile | |
Kosuke Sugiyama | Exec MD | Profile | |
Shinichi Murayama | Exec Director | Profile | |
Nobuo Tsutsumi | Mgmt Dept | Profile | |
Mitsumasa Kabashima | Pres Ltd | Profile |
About Hisamitsu Pharmaceutical Management Performance
The success or failure of an entity such as Hisamitsu Pharmaceutical often depends on how effective the management is. Hisamitsu Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hisamitsu management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hisamitsu management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. HISAMITSU PHARMA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2770 people.
Hisamitsu Pharmaceutical Workforce Analysis
Traditionally, organizations such as Hisamitsu Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Hisamitsu Pharmaceutical within its industry.Hisamitsu Pharmaceutical Manpower Efficiency
Return on Hisamitsu Pharmaceutical Manpower
Revenue Per Employee | 43.2M | |
Revenue Per Executive | 12B | |
Net Income Per Employee | 3.5M | |
Net Income Per Executive | 965.8M |
Complementary Tools for Hisamitsu Stock analysis
When running Hisamitsu Pharmaceutical's price analysis, check to measure Hisamitsu Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hisamitsu Pharmaceutical is operating at the current time. Most of Hisamitsu Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Hisamitsu Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hisamitsu Pharmaceutical's price. Additionally, you may evaluate how the addition of Hisamitsu Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |